Summit Therapeutics Inc.
SMMTNASDAQHealthcareBiotechnology
Regular session
$12.36
−$0.80 · -6.08%
SMMT company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Sell
Trim exposure — unfavorable risk-reward
Valuation
27
Expensive
Momentum
29
Weakening
Sentiment
65
Bullish
Risk resilience
43
Elevated Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteSummit Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing therapeutic solutions, primarily targeting infectious diseases across the United States and Latin America. The company's clinical development pipeline is heavily concentrated on therapies for Clostridioides difficile infection (CDI). Its flagship product candidate, ridinilazole, is an orally administered small molecule antibiotic currently advancing through Phase III clinical trials as a treatment for CDI. Beyond its lead asset, Summit Therapeutics is also progressing SMT-738, designed to combat multidrug-resistant infections, notably carbapenem-resistant Enterobacteriaceae (CRE). Additionally, its DDS-04 series represents a potential therapeutic avenue for various infections caused by the Enterobacteriaceae family of bacteria. Established in 2003, the company maintains its headquarters in Cambridge, Massachusetts.
- Industry
- Biotechnology
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Robert W. Duggan
- Listed since
- Mar 5, 2015
- Employees
- 265
Market position
Day range
Current $12.36
52-week range
Current $12.36
- Open
- $13.07
- Previous close
- $13.16
- Volume
- 922.17K
- 0.18× average
- Average volume
- 5.23M
- Average daily volume
- Market cap
- 9.86B USD
- Beta
- -1.24
- Market reference 1
- 50-day average
- $14.1043
- -12.37% below average
- 200-day average
- $16.5922
- -25.51% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- P/E (TTM)
- -11.04×
- P/B (TTM)
- 15.27×
- P/S (TTM)
- 0×
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 0.00%
- Operating margin
- 0.00%
- Net margin
- 0.00%
Financial health
- Debt / equity
- 0.03×
Earnings
- Latest fiscal-year EPS
- -1.44
- FY2025
- Latest fiscal-year revenue
- 0 USD
- FY2025
- Next fiscal-year EPS consensus
- -1.19
- FY2026 · 8 analysts
- Next fiscal-year revenue consensus
- 3.66M USD
- FY2026 · 10 analysts
Annual EPS trend
Reported history and fiscal-year consensus
Annual revenue trend
Reported history and fiscal-year consensus
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$26.00
110.36% upsidePrice history unavailable
High $38.00Average $26.00Low $15.00Rating distribution
22 ratingsSMMT peers
ETFs holding SMMT
Funds reporting this stock among their holdings, ordered by reported position size.
State Street SPDR S&P Biotech ETFXBI97.08M0.85%11.39B USD0.35%$163.03-1.63%
Vanguard Morningstar Total Stock Market ETFVTI48.52M0.00%2.3T USD0.03%$377.27-0.26%
Vanguard Morningstar Small-Cap ETFVB34.87M0.02%183.4B USD0.03%$303.63-0.37%
Vanguard Extended Market ETFVXF23.29M0.02%93.7B USD0.05%$244.16-0.56%
Vanguard Morningstar Small-Cap Value ETFVBR22.13M0.03%68.3B USD0.05%$249.3+0.05%
iShares Biotechnology ETFIBB13.16M0.12%10.75B USD0.44%$211.16-1.12%
iShares Russell Mid-Cap Growth ETFIWP10.35M0.05%20.62B USD0.23%$141.87-1.25%
iShares Russell Mid-Cap ETFIWR7.19M0.01%57.66B USD0.18%$113.16-0.24%State Street SPDR S&P Biotech ETFXBI- Market value
- 97.08M
- Weight
- 0.85%
- AUM
- 11.39B USD
- Expense ratio
- 0.35%
- Price / 1D
- $163.03-1.63%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 48.52M
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $377.27-0.26%
Vanguard Morningstar Small-Cap ETFVB- Market value
- 34.87M
- Weight
- 0.02%
- AUM
- 183.4B USD
- Expense ratio
- 0.03%
- Price / 1D
- $303.63-0.37%
Vanguard Extended Market ETFVXF- Market value
- 23.29M
- Weight
- 0.02%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $244.16-0.56%
Vanguard Morningstar Small-Cap Value ETFVBR- Market value
- 22.13M
- Weight
- 0.03%
- AUM
- 68.3B USD
- Expense ratio
- 0.05%
- Price / 1D
- $249.3+0.05%
iShares Biotechnology ETFIBB- Market value
- 13.16M
- Weight
- 0.12%
- AUM
- 10.75B USD
- Expense ratio
- 0.44%
- Price / 1D
- $211.16-1.12%
iShares Russell Mid-Cap Growth ETFIWP- Market value
- 10.35M
- Weight
- 0.05%
- AUM
- 20.62B USD
- Expense ratio
- 0.23%
- Price / 1D
- $141.87-1.25%
iShares Russell Mid-Cap ETFIWR- Market value
- 7.19M
- Weight
- 0.01%
- AUM
- 57.66B USD
- Expense ratio
- 0.18%
- Price / 1D
- $113.16-0.24%
Continue in GoAI
Research SMMTresearch.disclaimer